Sling Therapeutics, Inc.
A clinical-stage biotechnology company developing an oral drug candidate for thyroid eye disease.
$123MSeries C
LeadLoading investors…
Activity from announced rounds
A clinical-stage biotechnology company developing an oral drug candidate for thyroid eye disease.
A clinical-stage immunotherapy company is advancing an engineered CTLA-4 antibody for earlier cancer treatment.